Literature DB >> 2850407

[Mechanism and significance of arteriolar media hypertrophy/ hyperplasia in arterial hypertension. Role of the Na+/H+ antiport].

R Düsing1, B Göbel, B Weisser, D Dittrich, S Kraemer, H Vetter.   

Abstract

The most common haemodynamic abnormality in human essential hypertension is an increase in systemic vascular resistance. Morphologic substrate for increased flow resistance is a narrowing of the lumen of arteriolar resistance vessels. During the course of essential hypertension, this is associated with an increase in wall (mainly media) thickness due to hypertrophy and hyperplasia of vascular smooth muscle cells. In contrast to concepts interpreting media thickening strictly as structural adaptation to increased perfusion pressure, various lines of evidence also point to pressure independent factors. In this context, extracellular factors such as "growth factors" as well as alterations in the activity of intracellular messenger systems must be considered. Recent studies suggest that substances generally known to act as vasoconstrictors such as angiotensin II, noradrenaline and arginine-vasopressin may also stimulate vascular smooth muscle cell growth and proliferation. Intracellular messenger systems with possible significance in the response to trophins and/or mitogens of vascular smooth muscle cells are phospholipase C, protein kinase C and the Na+/H+-antiport. These systems have been demonstrated to be altered in hypertension supporting the concept that one endogenous factor in human essential hypertension with pathophysiological significance, at least in a subgroup of patients, may be an enhanced reactivity of vascular smooth muscle cells to trophic and mitogenic stimuli. In this context, intracellular messenger systems such as phospholipase C, protein kinase C and/or the Na+/H+-antiport may play an important pathophysiological role.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850407     DOI: 10.1007/bf01727661

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  77 in total

1.  Sodium transport and hypertension. Where are we going?

Authors:  M P Blaustein
Journal:  Hypertension       Date:  1984 Jul-Aug       Impact factor: 10.190

Review 2.  Mechanisms of active H+ secretion in the proximal tubule.

Authors:  P S Aronson
Journal:  Am J Physiol       Date:  1983-12

Review 3.  Trophic effects of peripheral adrenergic nerves on vascular structure.

Authors:  R D Bevan
Journal:  Hypertension       Date:  1984 Nov-Dec       Impact factor: 10.190

4.  Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro.

Authors:  M Campbell-Boswell; A L Robertson
Journal:  Exp Mol Pathol       Date:  1981-10       Impact factor: 3.362

5.  Lymphocyte membrane sodium-proton exchange in spontaneously hypertensive rats.

Authors:  P U Feig; M A D'Occhio; J W Boylan
Journal:  Hypertension       Date:  1987-03       Impact factor: 10.190

6.  Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension.

Authors:  A B Weder
Journal:  N Engl J Med       Date:  1986-01-23       Impact factor: 91.245

7.  Inositol 1,4,5-trisphosphate and the endoplasmic reticulum Ca2+ cycle of a rat insulinoma cell line.

Authors:  M Prentki; B E Corkey; F M Matschinsky
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

8.  Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscle.

Authors:  M L Fidelman; S H Seeholzer; K B Walsh; R D Moore
Journal:  Am J Physiol       Date:  1982-01

9.  High potassium diets markedly protect against stroke deaths and kidney disease in hypertensive rats, a possible legacy from prehistoric times.

Authors:  L Tobian
Journal:  Can J Physiol Pharmacol       Date:  1986-06       Impact factor: 2.273

10.  Kinetics of Na+ transport in Necturus proximal tubule.

Authors:  K R Spring; G Giebisch
Journal:  J Gen Physiol       Date:  1977-09       Impact factor: 4.086

View more
  1 in total

1.  Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers.

Authors:  Y D Ko; A Sachinidis; G H Graack; M Appenheimer; A J Wieczorek; R Düsing; H Vetter
Journal:  Clin Investig       Date:  1992-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.